Phase 2/3 Study of TLC590 for Postsurgical Pain Management

Clinical trial NCT05161637 · UNKNOWN

Trial details

NCT number: NCT05161637
Sponsor: Taiwan Liposome Company
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Postsurgical Pain Management

Start date: 2025-04-01
Primary completion: 2025-12-01
Enrollment: 415

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.